Stocksigma LogoStocksigma Logo

Senores Pharmaceuticals Schedules Q2 and H1 FY27 Earnings Call

Senores Pharmaceuticals Limited will host its Q2 and H1 FY27 post-results earnings conference call on 29th Oct'26 at 17:00 IST, following the release of

Senores Pharmaceuticals Schedules Q2 and H1 FY27 Earnings Call

Senores Pharmaceuticals Ltd 路 Intimation 路 29 Oct 2026, 5:00 pm

Senores Pharmaceuticals Schedules Q2 and H1 FY27 Earnings Call Senores Pharmaceuticals Limited will host its Q2 and H1 FY27 post-results earnings conference call on 29th Oct'26 at 17:00 IST, following the release of its un-audited standalone and consolidated financial results for the period ended 30th Sep'26. Organized by DAM Capital Advisors, the call will feature Managing Director Swapnil Shah, Chairman Sanjay Majmudar, and Whole Time Director & CFO Deval Shah to discuss financial performance. Universal dial-in numbers include +91 22 6280 1384 and +91 22 7115 8285, alongside international toll-free options.

Original exchange filing (PDF)

More announcements from Senores Pharmaceuticals Ltd

All Senores Pharmaceuticals Ltd announcements